FindTrial
Sign In

Two different cardiac imaging tests to assess heart valve disease

Severity assessment of valvular regurgitant lesion:Comparison of transthoracic and transesophageal echocardiography -A prospective study of patients who are undergoing transthoracic and transesophageal echocardiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/12/048369
Enrollment
170
Registered
2022-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere

Interventions

None listed

Sponsors

Deparment of Cardiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with regurgitant lesion undergoing transesophageal echocardiography

Exclusion criteria

Exclusion criteria: patients who are not willing to give the consent.

Design outcomes

Primary

MeasureTime frame
To correlate the severity assesment of valvular regurgitant lesion from transthorasic and transesophageal echocardiography and observe the agreement between them.Timepoint: 2years—

Secondary

MeasureTime frame
To differentiate the all qantitative and semi quantitative measurements in transthorasic and transesophageal echocardiography.Timepoint: 2years—

Countries

India

Contacts

Public ContactDr Krishnananda Nayak

MAHE

krishnananda.n@manipal.edu9964015487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026